These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10391999)

  • 1. Generation of alpha 1,3galactosyltransferase deficient mice.
    Thall AD
    Subcell Biochem; 1999; 32():259-79. PubMed ID: 10391999
    [No Abstract]   [Full Text] [Related]  

  • 2. T cells interacting with the alpha-Gal epitope: studies in alpha1, 3Galactosyltransferase knock-out mice.
    Tanemura M; Galili U
    Transplant Proc; 2000 Aug; 32(5):921-3. PubMed ID: 10936273
    [No Abstract]   [Full Text] [Related]  

  • 3. Genes coding for anti-Gal in knock-out mice for the alpha1, 3Galactosyltransferase gene: analysis by hybridomas.
    Chen ZC; Galili U
    Transplant Proc; 2000 Aug; 32(5):846-7. PubMed ID: 10936238
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1,3galactosyltransferase knock out mice.
    Chen ZC; Radic MZ; Galili U
    Mol Immunol; 2000 Jun; 37(8):455-66. PubMed ID: 11090880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of anti-Gal alpha 1-3Gal natural antibodies in sera of alpha 1,3-galactosyltransferase-deficient mice receiving Gal-positive bone marrow transplantation.
    Ohdan H; Yang YG; Sykes M
    Transplant Proc; 1999; 31(1-2):945-6. PubMed ID: 10083418
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of alpha 1,3-galactosyltransferase knockout mice.
    Tange M; Tearle R; Katerelos M; Crawford R; Robins A; Shinkel T; Pearse M; d'Apice AJ
    Transplant Proc; 1996 Apr; 28(2):620-1. PubMed ID: 8623306
    [No Abstract]   [Full Text] [Related]  

  • 8. alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies.
    Thall AD; Murphy HS; Lowe JB
    Transplant Proc; 1996 Apr; 28(2):556-7. PubMed ID: 8623267
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of alpha-Gal dependent hyperacute xenotransplant rejection using double knockout embryonic stem cells.
    Katayama A; Ogawa H; Kadomatsu K; Muramatsu H; Muramatsu T; Hayashi S; Yokoyama I; Takagi H
    Transplant Proc; 1997 Jun; 29(4):2262. PubMed ID: 9193617
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-galactose-alpha(1,3)Galactose antibody production in alpha1, 3-galactosyltransferase gene knockout mice after xeno- and allotransplantation.
    Chong AS; Blinder L; Ma L; Yin D; Shen J; Williams JW; Byrne G; Schwarz A; Diamond LS; Logan JE
    Transplant Proc; 2000 Aug; 32(5):844-5. PubMed ID: 10936237
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
    Deriy L; Ogawa H; Gao GP; Galili U
    Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope.
    Galili U
    Subcell Biochem; 1999; 32():1-23. PubMed ID: 10391989
    [No Abstract]   [Full Text] [Related]  

  • 13. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice.
    Ohdan H; Swenson KG; Kruger Gray HS; Yang YG; Xu Y; Thall AD; Sykes M
    J Immunol; 2000 Nov; 165(10):5518-29. PubMed ID: 11067905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of B cells with receptors for alpha-Gal epitopes (Galalpha 1-3Galbeta1-4GlcNac-R) in xenograft recipients.
    Tanemura M; Galili U
    Transplant Proc; 2000 Aug; 32(5):857-8. PubMed ID: 10936243
    [No Abstract]   [Full Text] [Related]  

  • 15. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase.
    LaTemple DC; Galili U
    Xenotransplantation; 1998 Aug; 5(3):191-6. PubMed ID: 9741457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve conduction velocity measurements reveal the functional deficit in ceramide galactosyl transferase-deficient (cgt-/-) mice.
    Haupt WF; Stoffel W
    J Neurol Sci; 2004 Jan; 217(1):83-8. PubMed ID: 14675614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene.
    Milland J; Christiansen D; Lazarus BD; Taylor SG; Xing PX; Sandrin MS
    J Immunol; 2006 Feb; 176(4):2448-54. PubMed ID: 16456004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-xenograft immune responses in alpha 1,3-galactosyltransferase knock-out mice.
    Pearse MJ; Cowan PJ; Shinkel TA; Chen CG; d'Apice AJ
    Subcell Biochem; 1999; 32():281-310. PubMed ID: 10392000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.